ClearBridge Investments’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-1,376
| Closed | -$20K | – | 1023 |
|
2020
Q1 | $20K | Sell |
1,376
-40
| -3% | -$581 | ﹤0.01% | 880 |
|
2019
Q4 | $39K | Sell |
1,416
-1
| -0.1% | -$28 | ﹤0.01% | 861 |
|
2019
Q3 | $41K | Sell |
1,417
-15
| -1% | -$434 | ﹤0.01% | 842 |
|
2019
Q2 | $40K | Sell |
1,432
-5
| -0.3% | -$140 | ﹤0.01% | 839 |
|
2019
Q1 | $48K | Sell |
1,437
-7
| -0.5% | -$234 | ﹤0.01% | 839 |
|
2018
Q4 | $42K | Buy |
1,444
+19
| +1% | +$553 | ﹤0.01% | 864 |
|
2018
Q3 | $66K | Sell |
1,425
-5
| -0.3% | -$232 | ﹤0.01% | 868 |
|
2018
Q2 | $53K | Sell |
1,430
-7
| -0.5% | -$259 | ﹤0.01% | 844 |
|
2018
Q1 | $42K | Hold |
1,437
| – | – | ﹤0.01% | 870 |
|
2017
Q4 | $49K | Buy |
1,437
+5
| +0.3% | +$170 | ﹤0.01% | 849 |
|
2017
Q3 | $52K | Buy |
1,432
+43
| +3% | +$1.56K | ﹤0.01% | 843 |
|
2017
Q2 | $36K | Buy |
+1,389
| New | +$36K | ﹤0.01% | 909 |
|
2015
Q3 | – | Sell |
-50
| Closed | -$2K | – | 1194 |
|
2015
Q2 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 1144 |
|
2015
Q1 | – | Sell |
-50
| Closed | -$2K | – | 1191 |
|
2014
Q4 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 1162 |
|